| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |